The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Xiaoyan ChuRaymond Evers

Abstract

In humans, creatinine is formed by a multistep process in liver and muscle and eliminated via the kidney by a combination of glomerular filtration and active transport. Based on current evidence, creatinine can be taken up into renal proximal tubule cells by the basolaterally localized organic cation transporter 2 (OCT2) and the organic anion transporter 2, and effluxed into the urine by the apically localized multidrug and toxin extrusion protein 1 (MATE1) and MATE2K. Drug-induced elevation of serum creatinine (SCr) and/or reduced creatinine renal clearance is routinely used as a marker for acute kidney injury. Interpretation of elevated SCr can be complex, because such increases can be reversible and explained by inhibition of renal transporters involved in active secretion of creatinine or other secondary factors, such as diet and disease state. Distinction between these possibilities is important from a drug development perspective, as increases in SCr can result in the termination of otherwise efficacious drug candidates. In this review, we discuss the challenges associated with using creatinine as a marker for kidney damage. Furthermore, to evaluate whether reversible changes in SCr can be predicted prospectively based on...Continue Reading

References

Jul 1, 1978·Clinical Pharmacology and Therapeutics·J W DubbF Alexander
Dec 1, 1975·The Journal of Urology·F BerglundR Pompeius
Apr 1, 1990·British Journal of Clinical Pharmacology·L F PrescottL M Manson
Nov 1, 1985·Kidney International·O ShemeshB D Myers
Jan 1, 1988·Annual Review of Medicine·A S LeveyN E Madias
May 1, 1987·British Journal of Clinical Pharmacology·A SomogyiF Bochner
Aug 1, 1984·British Journal of Clinical Pharmacology·A Somogyi, F Bochner
Dec 1, 1983·The American Journal of Medicine·J P BoschS Glabman
Jul 1, 1981·British Journal of Clinical Pharmacology·M K DuttT C Northfield
Mar 1, 1983·The American Journal of Clinical Nutrition·S B HeymsfieldS Moffitt
Aug 1, 1993·British Journal of Clinical Pharmacology·P T PollakS G Carruthers
May 1, 1993·Antimicrobial Agents and Chemotherapy·M OpravilR Lüthy
Feb 14, 1998·Kidney International·R C Blantz
Apr 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Luis CarrerasMarta Carrera
Oct 25, 2003·The Journal of Pharmacology and Experimental Therapeutics·Johan W Jonker, Alfred H Schinkel
Jun 24, 2004·Pharmaceutical Research·Yumiko UrakamiKen-ichi Inui
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Yoshihisa ShitaraYuichi Sugiyama
May 20, 2005·The Journal of Pharmacy and Pharmacology·Yasuna KobayashiToshinori Yamamoto
Sep 20, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nanda M VerhoevenCornelis Jakobs
Oct 20, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Sophie Séronie-VivienUNKNOWN Creatinine Working Group of the Société Française de Biologie Clinique
Oct 21, 2005·Journal of the American Society of Nephrology : JASN·Hiroki MiyazakiHitoshi Endou
Oct 3, 2006·Alcoholism, Clinical and Experimental Research·Nagisa AoyamaNorio Ozaki
Nov 14, 2006·Advanced Drug Delivery Reviews·Cheng ChangPeter W Swaan
Jan 19, 2007·Journal of the American Society of Nephrology : JASN·Yohannes HagosAndrew Bahn
Mar 16, 2007·Public Health Reports·R Monina KlevensDenise M Cardo
Oct 12, 2007·American Journal of Physiology. Renal Physiology·Erica E EdisonJohn T Brosnan
Oct 17, 2007·Annual Review of Pharmacology and Toxicology·Vishal S VaidyaJoseph V Bonventre
Jun 14, 2008·Pharmacogenetics and Genomics·Zhi-Jun WangMoses S S Chow
Dec 31, 2008·International Urology and Nephrology·Carlos G MussoJuan F Macías Núñez
Feb 27, 2009·Journal of the American Society of Nephrology : JASN·Sushrut S Waikar, Joseph V Bonventre
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jul 25, 2009·Clinical Pharmacology and Therapeutics·K K FilipskiA Sparreboom
Dec 25, 2009·Kidney International·Christoph EisnerJurgen Schnermann
Jan 8, 2010·American Journal of Physiology. Renal Physiology·Henriette E Meyer zu SchwabedissenRichard B Kim
Feb 27, 2010·Kidney International·Matthew D Breyer, Zhonghua Qi
Mar 2, 2010·Nature Reviews. Drug Discovery·UNKNOWN International Transporter ConsortiumLei Zhang
Mar 17, 2010·Pharmacology & Therapeutics·Rosalinde Masereeuw, Frans G M Russel
Apr 13, 2010·Nature Genetics·Anna KöttgenCaroline S Fox

❮ Previous
Next ❯

Citations

Mar 20, 2013·Molecular Aspects of Medicine·Sara El-GebaliPascale Anderle
Mar 25, 2017·Journal of Pharmaceutical Sciences·Hiroshi ArakawaIkumi Tamai
Sep 8, 2018·Toxicologic Pathology·Mary B NabityWarren E Glaab
Jan 4, 2019·Clinical Pharmacology in Drug Development·Taylor ChoiShyeilla V Dhuria
Nov 19, 2018·Clinical Pharmacology and Therapeutics·Jill C ChappellJoseph V Bonventre
Apr 26, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kimio TohyamaNobuyuki Amano
Nov 23, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hong ShenA David Rodrigues
Jan 11, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mackenzie C Bergagnini-KolevYvonne S Lin
Mar 1, 2018·Pharmacological Reviews·Fabian MüllerMartin F Fromm
Apr 12, 2020·Expert Opinion on Drug Metabolism & Toxicology·Kevin M HuangAlex Sparreboom
May 16, 2020·CPT: Pharmacometrics & Systems Pharmacology·Daniel ScotcherAleksandra Galetin
Aug 30, 2017·Expert Opinion on Drug Metabolism & Toxicology·Eve-Irene Lepist, Adrian S Ray
Oct 4, 2020·Current Opinion in Nephrology and Hypertension·Lesley A Inker, Juhi Chaudhari
Aug 28, 2020·Interactive Cardiovascular and Thoracic Surgery·Zhigang WangDongjin Wang
Aug 11, 2016·Clinical Pharmacology and Therapeutics·X ChuR Evers
Jun 1, 2017·Clinical Pharmacology and Therapeutics·A D RodriguesY Sugiyama
Sep 30, 2020·Journal of Clinical Pharmacology·Ariel R Topletz-EricksonChristopher J Endres
Oct 14, 2020·CPT: Pharmacometrics & Systems Pharmacology·Hiroyuki TakitaAleksandra Galetin
Dec 3, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Asami SaitoHiroyuki Kusuhara
Oct 30, 2020·International Journal of Molecular Sciences·Sophia L SamodelovMichele Visentin
Dec 16, 2020·European Journal of Clinical Pharmacology·M A C BruinA D R Huitema
Feb 9, 2021·Journal of Clinical Pharmacology·Tanay S SamantYan Ji
Jul 24, 2021·Lung Cancer : Targets and Therapy·Toshio FujinoTetsuya Mitsudomi

❮ Previous
Next ❯

Related Concepts

Related Feeds